AstraZeneca (AZN) Receives a Buy from Leerink Partners
In a report released on May 21, Andrew Berens from Leerink Partners maintained a Buy rating on AstraZeneca (AZN – Research Report). The company's shares closed yesterday at $70.41.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Berens covers the Healthcare sector, focusing on stocks such as Incyte, Arvinas Holding Company, and AstraZeneca. According to TipRanks, Berens has an average return of -6.7% and a 36.16% success rate on recommended stocks.
Currently, the analyst consensus on AstraZeneca is a Strong Buy with an average price target of $87.34.
The company has a one-year high of $87.68 and a one-year low of $61.24. Currently, AstraZeneca has an average volume of 6.03M.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
17 minutes ago
- Business Insider
Leader Capital Markets Sticks to Its Buy Rating for Teva (TEVA)
In a report released today, Sabina Levi from Leader Capital Markets maintained a Buy rating on Teva (TEVA – Research Report), with a price target of ILA9,300.00. The company's shares closed last Thursday at ILA6,205.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Levi is an analyst with an average return of -5.7% and a 0.00% success rate. Teva has an analyst consensus of Hold. TEVA market cap is currently ILs69.87B and has a P/E ratio of -14.31.
Business Insider
an hour ago
- Business Insider
Fangdd Network Group Ltd (ADR) trading halted, news pending
19:50 EDT Fangdd Network (DUO) Group Ltd (ADR) trading halted, news pending Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Business Insider
an hour ago
- Business Insider
Nektar trading halted, news pending
19:50 EDT Nektar (NKTR) trading halted, news pending Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
